BBI
VRTX icon

Baxter Bros Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Baxter Bros Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$716K Buy
1,441
+8
+0.6% +$3.54K 0.08% 108
2026
Q1 		$640K Sell
1,433
-31
-2% -$14.5K 0.08% 108
2025
Q4 		$664K Sell
1,464
-85
-5% -$36.6K 0.08% 106
2025
Q3 		$607K Buy
1,549
+108
+7% +$45.1K 0.07% 106
2025
Q2 		$642K Buy
1,441
+213
+17% +$98.2K 0.08% 98
2025
Q1 		$595K Buy
1,228
+206
+20% +$96K 0.08% 102
2024
Q4 		$412K Sell
1,022
-10
-1% -$4.63K 0.05% 115
2024
Q3 		$480K Buy
1,032
+52
+5% +$25K 0.06% 110
2024
Q2 		$463K Sell
980
-46
-4% -$20K 0.06% 112
2024
Q1 		$429K Buy
1,026
+130
+15% +$55K 0.06% 116
2023
Q4 		$365K Buy
896
+76
+9% +$28.1K 0.05% 121
2023
Q3 		$285K Hold
820
– – 0.04% 127
2023
Q2 		$289K Hold
820
– – 0.04% 117
2023
Q1 		$258K Sell
820
-68
-8% -$20.4K 0.04% 119
2022
Q4 		$256K Sell
888
-1
-0.1% -$305 0.04% 117
2022
Q3 		$257K Sell
889
-375
-30% -$108K 0.05% 116
2022
Q2 		$356K Sell
1,264
-175
-12% -$46.8K 0.06% 97
2022
Q1 		$376K Sell
1,439
-150
-9% -$35.6K 0.06% 101
2021
Q4 		$349K Sell
1,589
-300
-16% -$58.3K 0.05% 104
2021
Q3 		$343K Sell
1,889
-1,315
-41% -$257K 0.05% 105
2021
Q2 		$646K Sell
3,204
-214
-6% -$44.8K 0.1% 79
2021
Q1 		$734K Buy
3,418
+235
+7% +$51.6K 0.13% 76
2020
Q4 		$752K Buy
+3,183
New +$730K 0.14% 74

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baxter Bros Inc's VRTX Position: Q2 2026 in Review

Baxter Bros Inc increased its Vertex Pharmaceuticals (VRTX) stake by 0.56% in Q2 2026, buying an estimated $3.54K and bringing the position to 1,441 shares worth $716K. The position accounts for 0.08% of the portfolio, ranked #108.

Baxter Bros Inc first reported a position in VRTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $752K in Q4 2020. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Baxter Bros Inc held 1,441 shares of Vertex Pharmaceuticals worth $716K as of Q2 2026.
  • Baxter Bros Inc bought 8 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.54K.
  • Vertex Pharmaceuticals made up 0.08% of Baxter Bros Inc's portfolio in Q2 2026, its #108 holding.
  • Baxter Bros Inc first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Baxter Bros Inc's Vertex Pharmaceuticals position peaked at $752K in Q4 2020.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Baxter Bros Inc's 13F filing for Q2 2026, filed 6 Aug 2026.